These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 9558327)
1. Identification of amino acid residues associated with modulation of flavin-containing monooxygenase (FMO) activity by imipramine: structure/function studies with FMO1 from pig and rabbit. Wyatt MK; Overby LH; Lawton MP; Philpot RM Biochemistry; 1998 Apr; 37(17):5930-8. PubMed ID: 9558327 [TBL] [Abstract][Full Text] [Related]
2. The effect of arginine-428 mutation on modulation of activity of human liver flavin monooxygenase 3 (FMO3) by imipramine and chlorpromazine. Adali O; Carver GC; Philpot RM Exp Toxicol Pathol; 1999 Jul; 51(4-5):271-6. PubMed ID: 10445381 [TBL] [Abstract][Full Text] [Related]
3. Modulation of human flavin-containing monooxygenase 3 activity by tricyclic antidepressants and other agents: importance of residue 428. Adali O; Carver GC; Philpot RM Arch Biochem Biophys; 1998 Oct; 358(1):92-7. PubMed ID: 9750169 [TBL] [Abstract][Full Text] [Related]
4. Prochiral sulfoxidation as a probe for multiple forms of the microsomal flavin-containing monooxygenase: studies with rabbit FMO1, FMO2, FMO3, and FMO5 expressed in Escherichia coli. Rettie AE; Lawton MP; Sadeque AJ; Meier GP; Philpot RM Arch Biochem Biophys; 1994 Jun; 311(2):369-77. PubMed ID: 8203899 [TBL] [Abstract][Full Text] [Related]
5. Size limits of thiocarbamides accepted as substrates by human flavin-containing monooxygenase 1. Kim YM; Ziegler DM Drug Metab Dispos; 2000 Aug; 28(8):1003-6. PubMed ID: 10901713 [TBL] [Abstract][Full Text] [Related]
6. N-Glycosylation of pig flavin-containing monooxygenase form 1: determination of the site of protein modification by mass spectrometry. Korsmeyer KK; Guan S; Yang ZC; Falick AM; Ziegler DM; Cashman JR Chem Res Toxicol; 1998 Oct; 11(10):1145-53. PubMed ID: 9778310 [TBL] [Abstract][Full Text] [Related]
7. Deletion of the mouse Fmo1 gene results in enhanced pharmacological behavioural responses to imipramine. Hernandez D; Janmohamed A; Chandan P; Omar BA; Phillips IR; Shephard EA Pharmacogenet Genomics; 2009 Apr; 19(4):289-99. PubMed ID: 19262426 [TBL] [Abstract][Full Text] [Related]
8. Characterization and modulation by drugs of sheep liver microsomal flavin monooxygenase activity. Can Demirdöğen B; Adali O Cell Biochem Funct; 2005; 23(4):245-51. PubMed ID: 15473006 [TBL] [Abstract][Full Text] [Related]
10. Investigation of structure and function of a catalytically efficient variant of the human flavin-containing monooxygenase form 3. Borbás T; Zhang J; Cerny MA; Likó I; Cashman JR Drug Metab Dispos; 2006 Dec; 34(12):1995-2002. PubMed ID: 16985102 [TBL] [Abstract][Full Text] [Related]
11. Tissue-specific expression of flavin-containing monooxygenase (FMO) forms 1 and 2 in the rabbit. Shehin-Johnson SE; Williams DE; Larsen-Su S; Stresser DM; Hines RN J Pharmacol Exp Ther; 1995 Mar; 272(3):1293-9. PubMed ID: 7891346 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of xenobiotic N- and S-oxidation by variant flavin-containing monooxygenase 1 (FMO1) enzymes. Furnes B; Schlenk D Toxicol Sci; 2004 Apr; 78(2):196-203. PubMed ID: 14976351 [TBL] [Abstract][Full Text] [Related]
13. Alternative processing events in human FMO genes. Lattard V; Zhang J; Cashman JR Mol Pharmacol; 2004 Jun; 65(6):1517-25. PubMed ID: 15155844 [TBL] [Abstract][Full Text] [Related]
14. Cerebral flavin-containing monooxygenase-mediated metabolism of antidepressants in brain: immunochemical properties and immunocytochemical localization. Bhamre S; Bhagwat SV; Shankar SK; Williams DE; Ravindranath V J Pharmacol Exp Ther; 1993 Oct; 267(1):555-9. PubMed ID: 8229786 [TBL] [Abstract][Full Text] [Related]
15. Molecular cloning, sequencing, and expression in Escherichia coli of mouse flavin-containing monooxygenase 3 (FMO3): comparison with the human isoform. Falls JG; Cherrington NJ; Clements KM; Philpot RM; Levi PE; Rose RL; Hodgson E Arch Biochem Biophys; 1997 Nov; 347(1):9-18. PubMed ID: 9344459 [TBL] [Abstract][Full Text] [Related]
16. Expression of two different FMOs in sheep liver. Longin-Sauvageon C; Lattard V; Lilaz-Michel C; Buronfosse T; Benoit E Drug Metab Dispos; 1998 Mar; 26(3):284-7. PubMed ID: 9492394 [TBL] [Abstract][Full Text] [Related]
17. Cloning, sequencing, and tissue-dependent expression of flavin-containing monooxygenase (FMO) 1 and FMO3 in the dog. Lattard V; Longin-Sauvageon C; Lachuer J; Delatour P; Benoit E Drug Metab Dispos; 2002 Feb; 30(2):119-28. PubMed ID: 11792679 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of purified and membrane-bound flavin-containing monooxygenase 1 by (N,N-dimethylamino)stilbene carboxylates. Clement B; Weide M; Ziegler DM Chem Res Toxicol; 1996; 9(3):599-604. PubMed ID: 8728504 [TBL] [Abstract][Full Text] [Related]
19. Oxidation of cysteine S-conjugates by rabbit liver microsomes and cDNA-expressed flavin-containing mono-oxygenases: studies with S-(1,2-dichlorovinyl)-L-cysteine, S-(1,2,2-trichlorovinyl)-L-cysteine, S-allyl-L-cysteine, and S-benzyl-L-cysteine. Ripp SL; Overby LH; Philpot RM; Elfarra AA Mol Pharmacol; 1997 Mar; 51(3):507-15. PubMed ID: 9058607 [TBL] [Abstract][Full Text] [Related]
20. Molecular cloning of mouse liver flavin containing monooxygenase (FMO1) cDNA and characterization of the expression product: metabolism of the neurotoxin, 1,2,3,4-tetrahydroisoquinoline (TIQ). Itoh K; Nakamura K; Kimura T; Itoh S; Kamataki T J Toxicol Sci; 1997 Feb; 22(1):45-56. PubMed ID: 9076656 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]